Abstract
Breast cancer risk is high in industrialized societies, and increases as developing countries become more Westernized. The reasons are poorly understood. One possibility is circadian disruption from aspects of modern life, in particular the increasing use of electric power to light the night, and provide a sun-free environment during the day inside buildings. Circadian disruption could lead to alterations in melatonin production and in changing the molecular time of the circadian clock in the suprachiasmatic nuclei (SCN). There is evidence in humans that the endogenous melatonin rhythm is stronger for persons in a bright-day environment than in a dim-day environment; and the light intensity necessary to suppress melatonin at night continues to decline as new experiments are done. Melatonin suppression can increase breast tumorigenesis in experimental animals, and altering the endogenous clock mechanism may have downstream effects on cell cycle regulatory genes pertinent to breast tissue development and susceptibility. Therefore, maintenance of a solar day-aligned circadian rhythm in endogenous melatonin and in clock gene expression by exposure to a bright day and a dark night, may be a worthy goal. However, exogenous administration of melatonin in an attempt to achieve this goal may have an untoward effect given that pharmacologic dosing with melatonin has been shown to phase shift humans depending on the time of day it’s given. Exogenous melatonin may therefore contribute to circadian disruption rather than alleviate it.
Similar content being viewed by others
References
Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000: the global picture. Eur J Cancer 37:S4–S66
Nagata C, Kawakami N, Shimizu H (1997) Trends in the incidence rate and risk factors for breast cancer in Japan. Breast Cancer Res Treat 44:75–82
Madigan MP, Ziegler RG, Benichou J, et al. (1995) Proportion of breast cancer cases in the United States explained by well-established risk factors. JNCI 87:1681–1685
Stevens RG, Rea MS (2001) Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12:279–287
Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW (1992) Electric power, pineal function, and the risk of breast cancer. FASEB J 6:853–860
Pukkala E, Auvinen A, Wahlberg G (1995) Incidence of cancer among Finnish airline cabin attendants, 1967–92. Brit Med J 311:649–652
Tynes T, Hannevik M, Andersen A, et al. (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7:197–204
Hansen J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74–77
Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. JNCI 93:1557–1562
Schernhammer ES, Laden L, Speizer FE, et al. (2001) Rotating night shifts and risk of breast cancer in women participating in the Nurses’ Health Study. JNCI 93:1563–1568
Hahn RA (1991) Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2:208–210
Feychting M, Österlund B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9:490–494
Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko S-L (1999) Inverse association between breast cancer incidence and degree of visual impairment in Finland. Brit J Cancer 80:1459–1460
Kliukiene J, Tynes T, Andersen A (2001) Risk of breast cancer among Norwegien women with visual impairment. Br J Cancer 84:397–399
Stevens RG (1987) Review and Commentary. Electric power use and breast cancer a: hypothesis. Am J Epidemiol 125:556–561
Cohen M, Lippman M, Chabner B (1978) Role of the pineal gland in the aetiology and treatment of breast cancer. Lancet 2:814–881
Shah PN, Mhatre MC, Kothari LS (1984) Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res 44:3403–3407
Brzezinski A (1997) Melatonin in humans. N Engl J Med 336:186–195
Penny R, Stanczyk F, Goebelsmann U (1987) Melatonin: data consistent with a role in controlling ovarian function. J Endocrinol Invest 10:499–505
Kauppila A, Kilevä A, Pakarinen A, Vakkuri O (1987) Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. J Clin Endocrinol Metab. 65:823–828
Baumgartner A, Dietzel M, Saletu B, et al. (1993) Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women. Psychiatr Res 48:153–178
Sanchez-Barcelo EJ, Cos S, Fernandez R, Mediavilla D (2003) Melatonin and mammary cancer: a short review. Endocr-Relat Cancer 10:153–159
Pawlikoski M, Kolomecka M, Wojtczak A, Karasek M (2002) Effects of six months melatonin treatment on sleep quality and serum concentrations of estrtadiol, cortosil dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuroendocrinol Lett 23(suppl 1):17–19
Graham C, Cook MR, Gerkovich MM, Sastre A (2001) Examination of the melatonin hypothesis in women exposed at night to EMF and bright light. Environ Health Perspect 109:501–507
Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE (2004) Epidemiology of uriniary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomark Prev 13:936–943
Stevens RG (2005). Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 16:254–258
Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144:131–136
Blask DE, Dauchy RT, Sauer LA, et al. (2003) Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Res Treat 79:313–320
Travis RC, Allen DS, Fentiman IS, Key TJ (2004) Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 96:475–482
Key TJ, for the The Endogenous Hormones, Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616
Fu L, Lee CC (2003) The circadian clock: pacemaker and tumor suppressor Nature Reviews. Cancer 3:350–361
Blask DE, Pelletier DB, Hill SM, et al. (1991) Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J Cancer Res Clin Oncol 117:526–532
Blask DE, Wilson ST, Zalatan F (1997) Physiological melatonin inhibition of human breast cancer cell growth in vitro evidence for a glutathione-mediated pathway. Cancer Res 57:1909–1914
Hill SM, Spriggs LL, Simon MA, Muraoka H, Blask DE (1992) The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen system. Cancer Lett 64:249–256
Sephton S, Spiegel D (2003) Circadian disruption and cancer: a neuroendocrine-immune pathway from stress to disesase. Brain Behav Immun 17:321–328
Amir S, Stewart J (1999) The effectiveness of light on the circadian clock is linked to its emotional value. Neurosci 88:339–345
Wirz-Justice A, Krauchi K, Cajochen C, Danilenko KV, Renz C, Weber JM (2004) Evening melatonin and bright light administration induce additive phase shifts in dim light melatonin onset. J Pineal Res. 36:192–194
Lewy AJ, Wehr TA, Goodwin FK, et al. (1980) Light suppresses melatonin secretion in humans. Science 210:1267–1269
Brainard GC, Hanifin JP, Greeson JM, et al. (2001) Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 21:6405–6412
Khalsa SBS, Jewett ME, Cajochen C, Czeisler CA (2003) A phase response curve to single bright light pulses in human subjects. J Physiol 549:945–952
Hebert M, Martin SK, Lee C, Eastman CI (2002) The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res 33:198–203
Jöchle W (1964) Trends in photophysiologic concepts. Ann NY Acad Sci 117:88–104
Lucas RJ, Freedman MS, Muñoz M, Garcia-Fernández JM, Foster RG (1999) Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. Science 284:505–507
Khaetski IK (1965) Effect of hypothalamo-pituitary lesions induced by constant illumination on development of induced mammary tumors in rats. Vopr Exp Oncol (Kiev) 1:87–93
Anisimov VN (2002) The light-dark regimen and cancer development. Neuroendocrinol Lett 23(suppl 2):28–36
Anderson LE, Morris JE, Sasser LB, Stevens RG (2000) Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett 148:121–126
Russo IH, Russo J (1996) Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104:938–967
Russo IH, Mailo D, Morris JE, Anderson LE, Stevens RG (2004) Artificial Light and Circadian Rhythms: Influence of Age and Length of Exposure to Constant light on Mammary Gland Development and Cancer Risk. meeting abstract, ‘Emerging Topics in Breast Cancer and the Environment’. Organized by Breast Cancer and the Environment Research Centers, NIH. Princeton, NJ, November 4–6, 2004
Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero?. Lancet 335:939–940
Potischman N, Troisi R (1999) In utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control 10:561–573
Horne JA, Östberg O (1976) A self assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 4:97–110
Griefahn B, Künemund C, Golka K, et al. (2002) Melatonin synthesis: a possible indicator of intolerance to shiftwork. Am J Indus Med 42:427–436
Griefahn B (2002) The validity of the temporal parameters of the daily rhythm of melatonin levels as an indicator of morningness. Chrono Int 19:561–577
Schernhammer ES, Laden F, Speizer FE, et al. (2003) Night-shift work and risk of colorectal cancer in the Nurses’ Health Study. J Natl Cancer Inst. 95:825–888
Zhang Y, Felson DT, Ellison RC, et al. (2001) Bone mass and the risk of colon cancer among postmenopausal women. Am J Epidemiol 153:31–37
Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD (2002) Postmenopausal hormone replacement therapy. JAMA 288:872–881
Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M (2001) Entrainment of the circadian clock in the liver by feeding. Science 291:490–493
Damioloa F, Minh NL, Preitner N, Kornmann B, Fleury-Olela F, Schibler U (2000) Restricted feeding uncouples circadian oscillators in periferl tissues from the central pacemaker in the suprachiasmatic nucleus. Gene Devlop 14:2950–2961
Baird TJ, Briscoe RJ, Vallett M, Vanecek SA, Holloway FA, Gauvin DV (1998) Phase-reponse curve for ethanol: alterations in circadian rhythms of temperature and activity in rats . Pharmacol Biochem Behav 61:303–315
Allen GC, West JR, Chen WA, Earnest DJ (2004) Developmental alcohol exposure disrupts circadian regulation of BDNF in the rat suprachiasmatic nucleus. Neurotox Teratol 26:353–358
Farnell YZ, West JR, Chen WA, Allen GC, Earnest DJ (2004) Developmental alcohol exposure alters light-induced phase shifts of the circadian activity rhythm in rats. Alcohol Clin Exp Res 28:1020–1027
Beral V for the Collaborative Group on Hormonal Factors and Breast Cancer (2002) Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease Brit J Cancer 87:1234–1245
Stevens RG, Hiatt RA (1987) Alcohol, melatonin, and breast cancer. N Engl J Med 317:1287
Stevens RG, Hilakivi-Clarke L (2001) Alcohol exposure in utero and breast cancer risk later in life. Alcohol Alcoholism 36:276–277
Hilakivi-Clarke L, Cabanes A, De Assis S, Khan G, Shoemaker WJ, Stevens RG (2004). Low In Utero alcohol exposure increases mammary tumorigenesis in rats. Brit J Cancer 90:2224–2230
Moolgavkar SH, Day NE, Stevens RG (1980) Two-stage model for carcinogenesis: epidemiology of breast cancer in females. JNCI 65:559–569
Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health Study. Am J Epidemiol 152:950–964
Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T (2005) Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomark Prev 14:268–270
Hill AB (1965) The environment and disease: association or causation? Proc Royal Soc Med 58:295–300
Kawachi I, Colditz GA, Stampfer MJ, et al. (1995) Prospective study of shift work and risk of coronary heart disease in women. Circulation 92:3178–3182
Hansen J (2001) Editorial: light at night, shiftwork, and breast cancer risk. JNCI 93:1513–1515
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by grant ES11659 from the National Institute of Environmental Health Sciences.
Rights and permissions
About this article
Cite this article
Stevens, R.G. Artificial Lighting in the Industrialized World: Circadian Disruption and Breast Cancer. Cancer Causes Control 17, 501–507 (2006). https://doi.org/10.1007/s10552-005-9001-x
Issue Date:
DOI: https://doi.org/10.1007/s10552-005-9001-x